II
IOVA icon

Inspire Investing’s Iovance Biotherapeutics IOVA Stock Holding History

Inspire Investing’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46 Hold
11
– – ﹤0.01% 1239
2026
Q1 		$39 Hold
11
– – ﹤0.01% 1078
2025
Q4 		$30 Buy
+11
New +$25 ﹤0.01% 1089
2020
Q2 		– Sell
-18
Closed -$1K – 606
2020
Q1 		$1K Buy
+18
New +$477 ﹤0.01% 735
2018
Q1 		– Sell
-164
Closed -$1K – 439
2017
Q4 		$1K Buy
+164
New +$1.32K ﹤0.01% 869

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Inspire Investing's IOVA Position: Q2 2026 in Review

Inspire Investing held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 11 shares worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Inspire Investing first reported a position in IOVA in Q4 2017 and has held it in 5 quarters since. The position peaked at $1K in Q1 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Inspire Investing held 11 shares of Iovance Biotherapeutics worth $46 as of Q2 2026.
  • Inspire Investing left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1239 holding.
  • Inspire Investing first reported a position in Iovance Biotherapeutics in Q4 2017 and has held it in 5 quarters since.
  • Inspire Investing's Iovance Biotherapeutics position peaked at $1K in Q1 2020.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.